Specialist R&D Tax & Grant Funding Advisors

Transforming Cancer Therapeutics

UK registered businesses can apply for a share of up to £10 million to develop next generation immunotherapies for cancer or life-changing treatments for paediatric cancers.

Marc Greatrex

Director - Grants Division

11/01/2024

10 minute read


Up to £10 million in innovation projects to advance next-generation immunotherapies for cancer

Innovate UK, part of UK Research and Innovation, will invest up to £10 million in innovation projects to advance next-generation immunotherapies for cancer or life-changing treatment options for childhood cancers.

Your project can focus on one or more of the following:

  • next generation immunotherapies and immunomodulatory drugs
  • manipulation of the tumour microenvironment to promote immune responses against solid tumours
  • novel therapeutics that consider the unique characteristics of paediatric or young people’s cancers
  • clinical decision support tools to optimise treatment selection and therapeutic dosing for children and young people

This list is not intended to be exhaustive.

In applying to this competition, you are entering into a competitive process.

This competition closes at 11am UK time on the deadline stated.

Your project

Your project must:

  • have total costs between £150,000 and £4 million
  • not exceed a grant request of £2 million
  • have at least 50% of the total project costs shared by the SMEs, if collaborative
  • start by 1 Aug 2024
  • end by 31 July 2026
  • last between 6 and 24 months
  • carry out all of its project work in the UK
  • intend to exploit the results from or in the UK

Projects must always start on the first of the month and this must be stated within your application. Your project start date will be reflected in your grant offer letter if you are successful.

You must only include eligible project costs in your application. If you have requested an overall grant of over £500,000, and your online application is successful at written assessment, you may be invited to attend an interview.

Under current restrictions, this competition will not fund any procurement, commercial, business development or supply chain activity with any Russian or Belarusian entity as lead, partner or subcontractor. This includes any goods or services originating from a Russian or Belarusian source.

Who can apply?

To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME).

More information on the different types of organisation can be found in our Funding rules.

Academic institutions cannot lead or work alone.

Project team

To collaborate with the lead, your organisation must be one of the following UK registered:

  • business of any size
  • academic institution
  • charity
  • not for profit
  • public sector organisation
  • research and technology organisation (RTO)

Each partner organisation must be invited into the Innovation Funding Service (IFS) by the lead to collaborate on a project. Once partners have accepted the invitation, they will be asked to login or to create an account in IFS. They are responsible for entering their own project costs and completing their Project Impact questions in the application.

Partners must accept terms and conditions (T&Cs) and complete the subsidy question in order for the application to be submitted.

To be an eligible collaboration, the lead and at least one other organisation must apply for funding when entering their costs into the application.

Non-funded partners

Your project can include partners that do not receive any of this competition’s funding, for example non-UK businesses. Their costs will count towards the total project costs.

Subcontractors

Subcontractors are allowed in this competition.

Subcontractors can be from anywhere in the UK and you must select them through your usual procurement process.

You can use subcontractors from overseas but must make the case in your application as to why you could not use suppliers from the UK.

You must provide a detailed rationale, evidence of the potential UK contractors you approached and the reasons why they were unable to work with you. Innovate UK will not accept a cheaper cost as a sufficient reason to use an overseas subcontractor.

All subcontractor costs must be justified and appropriate to the total project costs.

Extenuating circumstances where overseas work may be allowable include, for example, clinical trial in a specific patient population. The application assessors will be asked to judge whether you have sufficiently made a case for the use of overseas subcontractors.

Number of applications

An SME can only lead on one application but can be included as a collaborator in two further applications.

If an SME is not leading any application, it can collaborate in any number of applications.

A large business, academic institution, research and technology organisation (RTO), charity, not for profit or public sector organisation can collaborate on any number of applications.

Proposals

The aim of this competition is to support innovation projects that focus on advancing next-generation immunotherapies for cancer or life-changing treatment options for childhood cancers.

Innovate UK will only support innovation projects conducted to the highest standards of animal welfare.

Further information for proposals involving animal testing is available at the UKRI Good Research Hub and NC3R’s animal welfare guidance.

Your project can include:

  • experimental evaluation at laboratory scale
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploration of potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy including phase 1 and 2 clinical trials
  • regulatory planning

Portfolio approach

Innovate UK want to fund a variety of projects across the immuno-oncology and paediatric oncology themes including broad technological maturities in various geographical locations across the UK. Innovate UK call this a portfolio approach.

Specific themes

Your project can focus on one or more of the following:

  • next generation immunotherapies and immunomodulatory drugs
  • manipulation of the tumour microenvironment to promote immune responses against solid tumours
  • novel therapeutics that consider the unique characteristics of paediatric or young people’s cancers
  • clinical decision support tools to optimise therapeutic dosing for children and young people

This list is not intended to be exhaustive.

Research categories:

Innovate UK will fund industrial research projects and experimental development projects as defined in the guidance on categories of research.
Projects Innovate UK will not fund

Innovate UK are not funding projects that are:

  • therapeutic approaches for adult cancers that do not support the development of immuno-oncology
  • cancer diagnostics that are not a companion diagnostic for a specific immunotherapeutic or paediatric oncology approach

Innovate UK cannot fund projects that are:

  • dependent on export performance, for example giving a subsidy to a baker on the condition that it exports a certain quantity of bread to another country
  • dependent on domestic inputs usage, for example giving a subsidy to a baker on the condition that it uses 50% UK flour in their product

Dates:

17 November 2023 - Online briefing event: watch the recording
24 January 2024 11:00am - Competition closes
20 February 2024 - Invite to interview
18 March 2024 - Interview panel
26 April 2024 - Applicants notified

Myriad Associates: Your Partner in Winning EU Grants for Cancer Research

At Myriad Associates, we're proud of our success in getting EU grants for important cancer research projects. Our expertise in this area is clear from our past achievements.

We have a strong history of securing funding, and you can see this in action through our work with ONK Therapeutics and EndoWave Ltd. These projects show our ability to help turn great ideas into funded research.

ONK Therapeutics – This company is leading the way in new cancer treatments. We played a key role in getting the EU funding they needed for their innovative work in cell therapy for cancer patients. Find out more about our work with them here.

EndoWave Ltd – They're changing how we treat cancer with less invasive methods. Our help in getting EU grants was vital for their advanced technology. Learn more about our partnership with them here.

We know how to navigate the complex world of grant applications and find the funding that can make a real difference in cancer research. With Myriad Associates, your innovative cancer treatment ideas have a partner ready to help them succeed.

Join us in making a difference in cancer research. Discover more about our work and how we can help your project at Myriad Associates Case Studies.

Interested in applying? Get in touch to learn how Myriad Associates can help:

  • Win Rate - Myriad Associates’ boast a near 70% success rate with Innovate UK grant applications. This is among the highest success rate in the industry.
  • Proven templates & tools for success - Our templates make it easy to collaborate & prepare a winning bid.
  • Honest & Trustworthy – We will not waste your time or money. If we feel your application won't succeed, we will tell you before we undertake the application process.
  • Highly rated UK & European bid writers - We have a highly experienced team of bid writers with proven UK & European success. We've secured over €80m in grant funding for our UK & EU clients.
  • Unlimited revisions - Our grant writers provide feedback on both successful and unsuccessful grant applications. We review this feedback with you to give you ongoing advice and guidance.
  • Risk-free Eligibility Call – Call us for a free eligibility call to see if you have an application worth applying for.

Click here to discuss your application with one of our expert grant bid writers or visit Innovate UK to find out more.

Where do I find more information?

For more information on this grant, please visit: https://apply-for-innovation-funding.service.gov.uk/competition/1797/overview/99bde36f-7c2d-44bc-8e83-3cf263742822 

Alternatively, contact us if you'd like to know whether your project would likely qualify for this grant.


Latest news

Get in touch

Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.

Contact us